News
CVSI
0.024
-4.00%
-0.001
Weekly Report: what happened at CVSI last week (0601-0605)?
Weekly Report · 5d ago
CV Sciences Shareholders Elect Directors, Reject Reverse Stock Split
TipRanks · 06/04 20:31
CV Sciences shareholders reject proposed reverse stock split at annual meeting
PUBT · 06/04 20:18
Weekly Report: what happened at CVSI last week (0525-0529)?
Weekly Report · 06/01 10:22
Weekly Report: what happened at CVSI last week (0518-0522)?
Weekly Report · 05/25 10:26
CV Sciences Earnings Call Balances Progress and Risk
TipRanks · 05/20 06:03
Weekly Report: what happened at CVSI last week (0511-0515)?
Weekly Report · 05/18 10:25
CV Sciences Earnings Call: Progress Amid CBD Headwinds
TipRanks · 05/16 00:20
CV Sciences Q1 FY26 net loss widens to $643,000; net sales fall 11.4% to $3.2 million
PUBT · 05/15 20:17
Cv Sciences outlines CMS program allowing up to $500 annually in hemp-derived products as it targets positive cash flow in H2 2026
Seeking Alpha · 05/14 22:51
CV Sciences Reports Q1 Results Amid Regulatory Headwinds
TipRanks · 05/14 21:20
CV Sciences Reports Q1 2026 Results: Full Earnings Call Transcript
Benzinga · 05/14 20:56
CV Sciences Q1 revenue falls 11% on lower sales volume
Reuters · 05/14 20:08
CV Sciences GAAP EPS of $0.00, revenue of $3.2M
Seeking Alpha · 05/14 20:01
CV Sciences Q1 Sales $3.195M Down From $3.606M YoY
Benzinga · 05/14 20:01
CV Sciences to report Q1 results after market close, host investor conference call
PUBT · 05/12 22:00
Weekly Report: what happened at CVSI last week (0504-0508)?
Weekly Report · 05/11 10:23
Weekly Report: what happened at CVSI last week (0427-0501)?
Weekly Report · 05/04 10:20
Weekly Report: what happened at CVSI last week (0420-0424)?
Weekly Report · 04/27 10:23
Roth views partial cannabis re-scheduling order as ‘extremely favorable’
TipRanks · 04/23 17:06
More
Webull provides a variety of real-time CVSI stock news. You can receive the latest news about Cv Sciences through multiple platforms. This information may help you make smarter investment decisions.
About CVSI
CV Sciences, Inc. is a consumer wellness company specializing in nutraceuticals and plant-based foods. The Company develops, manufactures, markets and sells herbal supplements, CBD products and plant-based food products under +PlusCBD, +PlusHLTH, Cultured Foods, and Lunar Fox brands in the healthcare market sector, including nutraceutical, beauty care, specialty foods, and pet products. Its hemp extracts, and other science-backed, natural ingredients and products are sold through a range of sales channels from business-to-business (B2B) to business-to-consumer (B2C). Its +PlusCBD line of products are available in softgels, tinctures, topicals, and gummies. Its Cultured Foods and Lunar Fox cater to individuals seeking vegan, gluten-free, or flexitarian options for a nutritious and satisfying culinary experience. Its +PlusHLTH is a line of cannabinoid-free supplements delivering targeted formulations for optimized health, improved performance and increased vitality.